Paper41283232
The Gut Microbiome Role in Multiple Myeloma: Emerging Insights and Therapeutic Opportunities.
George MY and 6 others. Hematol Rep, 2025. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. The Gut Microbiome Role in Multiple Myeloma: Emerging Insights and Therapeutic Opportunities. Papers, record 41283232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41283232
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Gut Microbiome Role in Multiple Myeloma: Emerging Insights and Therapeutic Opportunities.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References112
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38239921 | Lachnospiraceae are emerging industrial biocatalysts and biotherapeutics. | Front Bioeng Biotechnol | 2023 | https://conductscience.org/library/papers/38239921 | PubMed |
| 2 | 28546562 | The interplay between host immune cells and gut microbiota in chronic inflammatory diseases. | Exp Mol Med | 2017 | https://conductscience.org/library/papers/28546562 | PubMed |
| 3 | 35892821 | The Effect of the Gut Microbiota on Systemic and Anti-Tumor Immunity and Response to Systemic Therapy against Cancer. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35892821 | PubMed |
| 4 | 30257956 | Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant. | Sci Transl Med | 2018 | https://conductscience.org/library/papers/30257956 | PubMed |
| 5 | 8040890 | Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. | J Natl Cancer Inst | 1994 | https://conductscience.org/library/papers/8040890 | PubMed |
| 6 | 15563667 | Identification of helicobacter species in human liver samples from patients with primary hepatocellular carcinoma. | J Clin Pathol | 2004 | https://conductscience.org/library/papers/15563667 | PubMed |
| 7 | 162868 | Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats. | Cancer Res | 1975 | https://conductscience.org/library/papers/162868 | PubMed |
| 8 | 26160380 | MUCOSAL IMMUNOLOGY. The microbiota regulates type 2 immunity through RORγt⁺ T cells. | Science | 2015 | https://conductscience.org/library/papers/26160380 | PubMed |
| 9 | 29567829 | The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. | Cancer Discov | 2018 | https://conductscience.org/library/papers/29567829 | PubMed |
| 10 | 34072068 | CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34072068 | PubMed |
| 11 | 38283805 | An overview of multiple myeloma: A monoclonal plasma cell malignancy's diagnosis, management, and treatment modalities. | Saudi J Biol Sci | 2024 | https://conductscience.org/library/papers/38283805 | PubMed |
| 12 | 33369893 | Clinical effects and applications of the gut microbiome in hematologic malignancies. | Cancer | 2021 | https://conductscience.org/library/papers/33369893 | PubMed |
| 13 | 39645617 | Canagliflozin differentially modulates carfilzomib-induced endoplasmic reticulum stress in multiple myeloma and endothelial cells. | Arch Toxicol | 2025 | https://conductscience.org/library/papers/39645617 | PubMed |
| 14 | 23954158 | Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. | Cell Host Microbe | 2013 | https://conductscience.org/library/papers/23954158 | PubMed |
| 15 | 27268090 | Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target. | Blood | 2016 | https://conductscience.org/library/papers/27268090 | PubMed |
| 16 | 21034972 | Intestinal dendritic cells. | Adv Immunol | 2010 | https://conductscience.org/library/papers/21034972 | PubMed |
| 17 | 35211412 | Gene Expression Profiling in Multiple Myeloma: Redefining the Paradigm of Risk-Adapted Treatment. | Front Oncol | 2022 | https://conductscience.org/library/papers/35211412 | PubMed |
| 18 | 30941641 | T helper 17 (Th17) cells and interleukin-17 (IL-17) in cancer. | Arch Pharm Res | 2019 | https://conductscience.org/library/papers/30941641 | PubMed |
| 19 | 27117829 | Germ-free and Antibiotic-treated Mice are Highly Susceptible to Epithelial Injury in DSS Colitis. | J Crohns Colitis | 2016 | https://conductscience.org/library/papers/27117829 | PubMed |
| 20 | 33167336 | Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33167336 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42329290 | Canagliflozin attenuates Parkinson's disease and is associated with modulation of gut-inflammasome-brain axis in rats. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/42329290 | PubMed |
| 42068673 | Genetic architecture of multiple myeloma: From somatic alterations to germline susceptibility and clinical implications. | Transl Oncol | 2026 | https://conductscience.org/library/papers/42068673 | PubMed |
| 42068402 | Targeting the immunological synapse in multiple myeloma. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42068402 | PubMed |
| 41977190 | Oxidative Stress in Multiple Myeloma: Pathogenic Mechanisms, Biomarkers, and Redox-Targeted Therapeutic Strategies. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41977190 | PubMed |
| 41562912 | From Glucose Transport to Microbial Modulation: The Impact of Sodium Glucose Co-Transporter-2 Inhibitors on the Gut Microbiota. | Med Sci (Basel) | 2026 | https://conductscience.org/library/papers/41562912 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41283232
GET https://conductscience.org/api/papers/v1/41283232/references?page=2